Financial Architects Inc lessened its position in shares of Colgate-Palmolive (NYSE:CL) by 11.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,309 shares of the company’s stock after selling 304 shares during the quarter. Financial Architects Inc’s holdings in Colgate-Palmolive were worth $138,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently made changes to their positions in the company. Bank of New York Mellon Corp boosted its stake in Colgate-Palmolive by 8.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 20,135,385 shares of the company’s stock valued at $1,304,974,000 after buying an additional 1,596,825 shares in the last quarter. Morgan Stanley boosted its stake in Colgate-Palmolive by 15.0% in the 3rd quarter. Morgan Stanley now owns 7,212,524 shares of the company’s stock valued at $482,879,000 after buying an additional 941,008 shares in the last quarter. Assenagon Asset Management S.A. boosted its stake in Colgate-Palmolive by 376.6% in the 4th quarter. Assenagon Asset Management S.A. now owns 1,160,502 shares of the company’s stock valued at $69,073,000 after buying an additional 917,012 shares in the last quarter. Vanguard Group Inc boosted its stake in Colgate-Palmolive by 1.0% in the 3rd quarter. Vanguard Group Inc now owns 73,520,894 shares of the company’s stock valued at $4,922,224,000 after buying an additional 734,860 shares in the last quarter. Finally, Vanguard Group Inc. boosted its stake in Colgate-Palmolive by 1.0% in the 3rd quarter. Vanguard Group Inc. now owns 73,520,894 shares of the company’s stock valued at $4,922,224,000 after buying an additional 734,860 shares in the last quarter. 75.21% of the stock is currently owned by institutional investors.
Several analysts recently commented on the company. Zacks Investment Research lowered Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Wednesday, January 2nd. Wells Fargo & Co decreased their price target on Colgate-Palmolive from $64.00 to $62.00 and set a “market perform” rating on the stock in a research note on Wednesday, October 17th. Argus decreased their price target on Colgate-Palmolive from $75.00 to $70.00 and set a “buy” rating on the stock in a research note on Tuesday, October 30th. Evercore ISI assumed coverage on Colgate-Palmolive in a research note on Thursday, January 10th. They issued an “outperform” rating and a $70.00 price target on the stock. Finally, Morgan Stanley decreased their price target on Colgate-Palmolive from $65.00 to $60.00 and set a “hold” rating on the stock in a research note on Tuesday, October 30th. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and four have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $65.00.
Shares of CL opened at $65.69 on Monday. Colgate-Palmolive has a 52-week low of $57.41 and a 52-week high of $72.61. The firm has a market capitalization of $56.97 billion, a price-to-earnings ratio of 22.12, a price-to-earnings-growth ratio of 4.24 and a beta of 0.78.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 25th. The company reported $0.74 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.73 by $0.01. Colgate-Palmolive had a return on equity of 25,268.29% and a net margin of 15.44%. The firm had revenue of $3.81 billion during the quarter, compared to the consensus estimate of $3.78 billion. During the same quarter in the previous year, the company posted $0.75 EPS. The business’s revenue for the quarter was down 2.1% compared to the same quarter last year. On average, equities research analysts expect that Colgate-Palmolive will post 2.83 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 15th. Shareholders of record on Wednesday, January 23rd will be given a $0.42 dividend. The ex-dividend date is Tuesday, January 22nd. This represents a $1.68 annualized dividend and a yield of 2.56%. Colgate-Palmolive’s payout ratio is 56.57%.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.
Featured Story: Swap
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.